Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
about
Foamy virus budding and releaseRNA is a structural element in retrovirus particlesA replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeOpposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment.Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane.Murine leukemia virus Gag localizes to the uropod of migrating primary lymphocytesMinimal exclusion of plasma membrane proteins during retroviral envelope formation.Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus.Purification of infectious human herpesvirus 6A virions and association of host cell proteins.Trafficking of an acylated cytosolic protein: newly synthesized p56(lck) travels to the plasma membrane via the exocytic pathway.Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding.Retroviral matrix and lipids, the intimate interaction.Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex.Intracellular distribution of human T-cell leukemia virus type 1 Gag proteins is independent of interaction with intracellular membranes.Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system.Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion.Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.Caveolin-1 interacts with the Gag precursor of murine leukaemia virus and modulates virus production.Intracellular assembly and budding of the Murine Leukemia Virus in infected cellsTargeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.
P2860
Q27015997-B5C2DDF5-9048-4EFC-B0B6-3B44D501E9A8Q30054778-4B33F164-21DB-4496-A29C-E62B3C4E7242Q33621078-62B433DF-74BC-4AB5-90B4-BAF059688C9DQ33642818-A4B0C0AC-9CD1-4BE4-A609-DBE8F68A7010Q33802787-07EA703B-CCF7-4300-A7C1-84B7F9DB8CD6Q33806395-B2CA7590-8649-4C53-9AB6-510EE0FF33E5Q34152672-ECCAAE2B-9B9D-47EE-865F-1B1428886B5FQ34262061-6E1036A6-D177-400E-A41C-384E82488B7EQ35162499-36081B88-08C7-4118-A318-07A3676D6092Q35898075-183BD69F-B5A2-4588-97A7-45FD6FCC2979Q36310683-1E3D262F-E8DD-4E50-96FB-C4A6C11CD91BQ36342168-E6086A99-C364-495A-B4DA-EBFE0A0EF1F9Q37195958-A8B49B0F-E1C6-4E48-9C4B-5B989F0E336EQ37850839-8DEA06DB-B07E-4A5A-A64B-9EAA9701C637Q39551677-F64EE27C-8804-4482-A4C4-9AC8101AF112Q39579502-EB140045-4302-43D9-93B4-4C4BAA62A1F5Q39685937-3D08935D-DB36-40DC-AB1A-B365B0ED688FQ39685992-CBF6B253-F795-4424-AA62-BD0AE5319508Q39732657-B452E248-9139-4436-8EC7-9E1A78B08C02Q39741944-435F6D3B-353D-4DCA-B5EF-76175C96CBE2Q42028162-B5C98182-94F2-404B-8171-9B7A51766935Q42067429-A20BDA90-1D14-4D31-80B2-EBA0241559BCQ42115515-6BD3F714-B439-4704-A491-0238A34759E1Q42947265-72F7E43F-A25D-4503-9660-D859ED396D8F
P2860
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@ast
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@en
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@nl
type
label
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@ast
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@en
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@nl
prefLabel
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@ast
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@en
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@nl
P2093
P2860
P3181
P356
P1476
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
@en
P2093
K Hultenby
M Suomalainen
P2860
P304
P3181
P356
10.1083/JCB.135.6.1841
P407
P433
P577
1996-12-01T00:00:00Z